DEA Issues New Code for Extract
Cannabidiol (CBD) personal-care products include topical products such as patches, salves and oils, and are created from hemp, a cousin to marijuana. Some massage therapists, chiropractors and the general public have embraced CBD products for pain relief.
Now, many people in the cannabis industry are scrambling to interpret a new rule issued by the Drug Enforcement Administration (DEA) on Dec. 14 titled “Establishment of a New Drug Code for Marihuana Extract”—and to determine if it could affect manufacturers and distributors of hemp-derived products. The rule is scheduled to take effect Jan 13, 2017.
What has resulted is curiosity on the part of some hemp advocates regarding whether or not the new code will have an effect on the CBD industry.